Cargando…

Effects of polygenic risk for Alzheimer’s disease on rate of cognitive decline in normal aging

Most people’s cognitive abilities decline with age, with significant and partly genetically driven, individual differences in rate of change. Although APOE ɛ4 and genetic scores for late-onset Alzheimer’s disease (LOAD) have been related to cognitive decline during preclinical stages of dementia, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kauppi, Karolina, Rönnlund, Michael, Nordin Adolfsson, Annelie, Pudas, Sara, Adolfsson, Rolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381667/ https://www.ncbi.nlm.nih.gov/pubmed/32709845 http://dx.doi.org/10.1038/s41398-020-00934-y

Ejemplares similares

Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individuals
por: Koch, Elise, et al.
Publicado: (2021)

Short Leukocyte Telomeres, But Not Telomere Attrition Rates, Predict Memory Decline in the 20-Year Longitudinal Betula Study
por: Pudas, Sara, et al.
Publicado: (2020)

Short leukocyte telomeres predict 25-year Alzheimer's disease incidence in non-APOE ε4-carriers
por: Hackenhaar, Fernanda Schäfer, et al.
Publicado: (2021)

Elevated plasma neurofilament light in aging reflects brain white‐matter alterations but does not predict cognitive decline or Alzheimer's disease
por: Nyberg, Lars, et al.
Publicado: (2020)

Sixteen-Year Longitudinal Evaluation of Blood-Based DNA Methylation Biomarkers for Early Prediction of Alzheimer’s Disease
por: Schäfer Hackenhaar, Fernanda, et al.
Publicado: (2023)

Loneliness Increases the Risk of All-Cause Dementia and Alzheimer’s Disease
por: Sundström, Anna, et al.
Publicado: (2020)

APOE-ɛ4 effects on longitudinal decline in olfactory and non-olfactory cognitive abilities in middle-aged and old adults
por: Josefsson, Maria, et al.
Publicado: (2017)

Perceived Stress in Adults Aged 65 to 90: Relations to Facets of Time Perspective and COMT Val(158)Met Polymorphism
por: Rönnlund, Michael, et al.
Publicado: (2018)

Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer’s Disease and Longitudinal Change in Hippocampus Function
por: Salami, Alireza, et al.
Publicado: (2022)

Stressful life events are not associated with the development of dementia
por: Sundström, Anna, et al.
Publicado: (2014)

Traffic-Related Air Pollution and Dementia Incidence in Northern Sweden: A Longitudinal Study
por: Oudin, Anna, et al.
Publicado: (2015)

Polygenic predictors of age-related decline in cognitive ability
por: Ritchie, Stuart J., et al.
Publicado: (2019)

The genomics of major psychiatric disorders in a large pedigree from Northern Sweden
por: Szatkiewicz, Jin, et al.
Publicado: (2019)

APOE ɛ4, but not polygenic Alzheimer’s disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individuals
por: Håglin, Sofia, et al.
Publicado: (2023)

Free Recall Episodic Memory Performance Predicts Dementia Ten Years prior to Clinical Diagnosis: Findings from the Betula Longitudinal Study
por: Boraxbekk, Carl-Johan, et al.
Publicado: (2015)

Alzheimer’s Disease Polygenic Risk Score Is Not Associated With Cognitive Decline Among Older Adults With Type 2 Diabetes
por: Manzali, Sigalit B., et al.
Publicado: (2022)

Combining Polygenic Hazard Score With Volumetric MRI and Cognitive Measures Improves Prediction of Progression From Mild Cognitive Impairment to Alzheimer's Disease
por: Kauppi, Karolina, et al.
Publicado: (2018)

Neuropathology-Independent Association Between APOE Genotype and Cognitive Decline Rate in the Normal Aging-Early Alzheimer Continuum
por: Qian, Jing, et al.
Publicado: (2023)

Cognitive Capacity Genome-Wide Polygenic Scores Identify Individuals with Slower Cognitive Decline in Aging
por: Joo, Yoonjung Yoonie, et al.
Publicado: (2022)

Cognitive Decline in Alzheimer’s Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting
por: Euesden, Jack, et al.
Publicado: (2020)

Schizophrenia polygenic risk predicts general cognitive deficit but not cognitive decline in healthy older adults
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy Individuals
por: Koch, Elise, et al.
Publicado: (2022)

Cognitive Decline in Normal Ageing and Early Alzheimer’s Disease: A Continuous or Discontinuous Transition?
por: Spaan, Pauline E. J., et al.
Publicado: (2010)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
por: Bauer, Corinna M., et al.
Publicado: (2018)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
por: Porter, Tenielle, et al.
Publicado: (2018)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
por: Tomassen, Jori, et al.
Publicado: (2022)

Rates of Cognitive Decline in 100 Patients With Alzheimer Disease
por: Miyakawa-Liu, Monica, et al.
Publicado: (2022)

Rates of Decline in Alzheimer Disease Decrease with Age
por: Holland, Dominic, et al.
Publicado: (2012)

Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score
por: Desikan, Rahul S., et al.
Publicado: (2017)

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer’s Disease
por: Zahodne, Laura B., et al.
Publicado: (2013)

Polygenic Risk Score for Alzheimer’s Disease Is Associated With Ch4 Volume in Normal Subjects
por: Wang, Tao, et al.
Publicado: (2019)

Working Memory and Executive Function Decline across Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease
por: Kirova, Anna-Mariya, et al.
Publicado: (2015)

Glia and zinc in ageing and Alzheimer’s disease: a mechanism for cognitive decline?
por: Hancock, Sara M., et al.
Publicado: (2014)

Serum Metabolomic Biomarkers of Dementia
por: Mousavi, Malahat, et al.
Publicado: (2014)

Schizophrenia-Associated MIR204 Regulates Noncoding RNAs and Affects Neurotransmitter and Ion Channel Gene Sets
por: Cammaerts, Sophia, et al.
Publicado: (2015)

Polygenic association of glomerular filtration rate decline in world trade center responders
por: Koraishy, Farrukh M., et al.
Publicado: (2022)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

Subjective cognitive decline and rates of incident Alzheimer’s disease and non-Alzheimer’s disease dementia
por: Slot, Rosalinde E. R., et al.
Publicado: (2018)

Utility of Polygenic Risk Scoring to Predict Cognitive Impairment as Measured by Preclinical Alzheimer Cognitive Composite Score
por: Gao, Q., et al.
Publicado: (2022)

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
por: Qian, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lhotgmu0lsusml7pbj8npjve32